Rochester Medical announced it has entered into M&A deals with C. R. Bard at a price of $20 per share, or approximately $262 million in the aggregate. Read the full story
In M&A news, Simcere Pharmaceutical Group has entered into a merger agreement for around $495 million. Read the full story
In a business merger agreement, Takeda's wholly-owned subsidiary, Takeda America Holdings, will acquire LigoCyte for an upfront payment of $60 million, with future contingent consideration based on the progress of development projects Read the full story
In a complete business merger and takeover deal, Syngenta would buy Belgian hybrid seed firm Devgen for 403 million euros ($522 million), as the Swiss company strengthens its foothold in rice-growing Read the full story
Pfizer, the top pharma company entered in a business merger agreement with Zhejiang Hisun Pharmaceuticals to launch of Hisun-Pfizer Pharmaceuticals, a joint venture formed between the two companies to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets Read the full story
Luminex Corporation announced a definitive business merger agreement to acquire privately-held, GenturaDx.